Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aurobindo receives FDA ok for perindopril and escitalopram

This article was originally published in Scrip

Executive Summary

Aurobindo Pharmahas received tentative approvals from the US FDAfor perindopril erbumine tablets 2mg, 4mg and 8mg, generic versions ofSolvay Pharmaceuticals' antihypertensive, Aceon, and for escitalopram oxalate oral solution 5mg (base)/5ml, a generic version ofForest Laboratories' antidepressant, Lexapro. Aurobindo has received 85 ANDA approvals from the FDA, which include 61 final approvals and 24 tentative approvals.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC008094

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel